NHS subcutaneous immunotherapy 2026: who qualifies, what to expect, and how to ask your oncologist

The NHS now offers an injectable form of the cancer immunotherapy drug pembrolizumab that takes minutes rather than hours. Here is who it is for, how it differs from the drip, and how to bring it up with your care team.